Organon & Co.: Hyperlipidemias trials

The registry lists 10 Hyperlipidemias studies with Organon & Co. as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 1 2Phase 3 7No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)CompletedNCT00271817Phase 3Results posted
• A Study to Determine the Bioequivalence of SCH 900068 Compared to Marketed Products (Protocol No. P07551)CompletedNCT01236430Phase 1
• Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED)CompletedNCT00723723
• Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2)CompletedNCT00652431Phase 1
• Vytorin As Strategy To Reduce Dislipidemia In Adults (0653A-148)CompletedNCT00651560Phase 3
• Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578)CompletedNCT00552097Phase 3
• TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060)CompletedNCT00328523Phase 3
• A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)CompletedNCT00093899Phase 3
• Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)CompletedNCT00092573Phase 3
• Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)CompletedNCT00092560Phase 3